Register entry
- Registered sites
- 2
- Active NDC listings
- 37
- Live patents
- 0
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1Labelling1Finished drug manufacture2Packaging2Relabelling1Repackaging1
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| HK Kolmar Canada, IncRegistrant: HK Kolmar Canada Inc | 149 Victoria St., Barrie, ON L4N 2J6, Canada (CAN) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture, Packaging, Relabelling, Repackaging | 3002647523243501959 |
| HK Kolmar USA, LLC | 102 Life Science Drive, Olyphant, Pennsylvania (PA) 18447, United States (USA) | Labelling, Finished drug manufacture, Packaging | 1000221288809172885 |
Catalogue
Drug listings by form and route
3737 active NDC listings: 32 drug for further processing, 3 bulk ingredient, 2 human otc drug. By marketing category: DRUG FOR FURTHER PROCESSING 32, BULK INGREDIENT 2, OTC MONOGRAPH DRUG 2, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 1.
| Dosage form | NDCs |
|---|---|
| lotion | 25 |
| gel | 4 |
| aerosol, foam | 2 |
| cream | 2 |
| kit | 1 |
| oil | 1 |
| solution/ drops | 1 |
| suspension | 1 |
| Route | NDCs |
|---|---|
| topical | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| hk kolmar canada, inc | 37 |
Catalogue
Marketed products
37| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | oil | 49354-126DRUG FOR FURTHER PROCESSING |
| - | BENZALKONIUM CHLORIDE | aerosol, foam | 49354-065DRUG FOR FURTHER PROCESSING |
| Compound W Total Care Wart and Skin Kit | SALICYLIC ACID | kit | 49354-130OTC MONOGRAPH DRUG |
| - | HOMOSALATE, OCTISALATE, OXYBENZONE, AVOBENZONE, OCTOCRYLENE | lotion | 49354-051DRUG FOR FURTHER PROCESSING |
| - | SALICYLIC ACID | solution/ drops | 49354-049DRUG FOR FURTHER PROCESSING |
| - | SALICYLIC ACID | gel | 49354-050DRUG FOR FURTHER PROCESSING |
| - | SALICYLIC ACID | gel | 49354-052DRUG FOR FURTHER PROCESSING |
| - | SALICYLIC ACID | gel | 49354-053DRUG FOR FURTHER PROCESSING |
| - | SALICYLIC ACID | gel | 49354-076DRUG FOR FURTHER PROCESSING |
| - | TITANIUM DIOXIDE, ZINC OXIDE | cream | 49354-060DRUG FOR FURTHER PROCESSING |
| - | TITANIUM DIOXIDE, ZINC OXIDE | cream | 49354-062DRUG FOR FURTHER PROCESSING |
| - | TITANIUM DIOXIDE, ZINC OXIDE | lotion | 49354-082DRUG FOR FURTHER PROCESSING |
| - | TITANIUM DIOXIDE, ZINC OXIDE | lotion | 49354-083DRUG FOR FURTHER PROCESSING |
| - | TITANIUM DIOXIDE, ZINC OXIDE | lotion | 49354-084DRUG FOR FURTHER PROCESSING |
| - | TITANIUM DIOXIDE, ZINC OXIDE | lotion | 49354-161BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | TOLNAFTATE | suspension | 49354-080DRUG FOR FURTHER PROCESSING |
| X3 Clean Foaming Hand Sanitizer | BENZALKONIUM CHLORIDE | aerosol, foam, topical | 49354-055OTC MONOGRAPH DRUG |
| - | ZINC OXIDE | lotion | 49354-105DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-106DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-107DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-108DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-109DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-110DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-111DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-112DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-113DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-114DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-115DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-116DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-117DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-118DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-119DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-120DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-121DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-122DRUG FOR FURTHER PROCESSING |
| - | ZINC OXIDE | lotion | 49354-166BULK INGREDIENT |
| - | ZINC OXIDE | lotion | 49354-167BULK INGREDIENT |
Neighbours
Registered in the same town
1- Medipharm Laboratories, IncBarrie, CAN
Compare
Comparable companies in United States
- Deseret Laboratories Incorporated2 sites · 858 NDC
- Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
- PureTek Corporation2 sites · 178 NDC
- Cosmax Usa Corporation2 sites · 142 NDC
- Apotheca Company2 sites · 110 NDC
- Nivagen Pharmaceuticals LLC2 sites · 106 NDC
- GOJO Industries, LLC2 sites · 84 NDC
- KVK-TECH, INC.2 sites · 71 NDC
- Revlon Consumer Products Corporation2 sites · 61 NDC
- Samsung Biologics Co., Ltd.2 sites · 57 NDC
Enquiry
Common questions
- Is HK Kolmar Canada Inc FDA approved?
- HK Kolmar Canada Inc holds 2 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are HK Kolmar Canada Inc's drugs manufactured?
- At registered sites in Canada, the United States. The FDA register lists Barrie; Olyphant, PA. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, relabelling, repackaging.
- What drugs does HK Kolmar Canada Inc make?
- 37 products are listed under HK Kolmar Canada Inc in the openFDA NDC Directory, most often as lotion; gel; aerosol, foam. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.